249 related articles for article (PubMed ID: 34327399)
1. Incidence, mortality, and economic burden of myasthenia gravis in China: A nationwide population-based study.
Chen J; Tian DC; Zhang C; Li Z; Zhai Y; Xiu Y; Gu H; Li H; Wang Y; Shi FD
Lancet Reg Health West Pac; 2020 Dec; 5():100063. PubMed ID: 34327399
[TBL] [Abstract][Full Text] [Related]
2. Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals.
Alshekhlee A; Miles JD; Katirji B; Preston DC; Kaminski HJ
Neurology; 2009 May; 72(18):1548-54. PubMed ID: 19414721
[TBL] [Abstract][Full Text] [Related]
3. Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study.
Zheng P; Tian DC; Xiu Y; Wang Y; Shi FD
Lancet Reg Health West Pac; 2022 Jan; 18():100302. PubMed ID: 35024648
[TBL] [Abstract][Full Text] [Related]
4. Incidence of multiple sclerosis in China: A nationwide hospital-based study.
Tian DC; Zhang C; Yuan M; Yang X; Gu H; Li Z; Wang Y; Shi FD
Lancet Reg Health West Pac; 2020 Aug; 1():100010. PubMed ID: 34327341
[TBL] [Abstract][Full Text] [Related]
5. Incidence of neuromyelitis optica spectrum disorder (NMOSD) in China: A national population-based study.
Tian DC; Li Z; Yuan M; Zhang C; Gu H; Wang Y; Shi FD
Lancet Reg Health West Pac; 2020 Sep; 2():100021. PubMed ID: 34327375
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sugammadex on Postoperative Myasthenic Crisis in Myasthenia Gravis Patients: Propensity Score Analysis of a Japanese Nationwide Database.
Mouri H; Jo T; Matsui H; Fushimi K; Yasunaga H
Anesth Analg; 2020 Feb; 130(2):367-373. PubMed ID: 31124838
[TBL] [Abstract][Full Text] [Related]
7. Myasthenia gravis: a study from India.
Singhal BS; Bhatia NS; Umesh T; Menon S
Neurol India; 2008; 56(3):352-5. PubMed ID: 18974563
[TBL] [Abstract][Full Text] [Related]
8. Myasthenia gravis-treatment and severity in nationwide cohort.
Sobieszczuk E; Napiórkowski Ł; Szczudlik P; Kostera-Pruszczyk A
Acta Neurol Scand; 2022 Apr; 145(4):471-478. PubMed ID: 34981830
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis.
Xue L; Wang L; Dong J; Yuan Y; Fan H; Zhang Y; Wang Q; Ding J
Eur J Cardiothorac Surg; 2017 Oct; 52(4):692-697. PubMed ID: 29156018
[TBL] [Abstract][Full Text] [Related]
10. Mortality and survival in myasthenia gravis: a Danish population based study.
Christensen PB; Jensen TS; Tsiropoulos I; Sørensen T; Kjaer M; Højer-Pedersen E; Rasmussen MJ; Lehfeldt E
J Neurol Neurosurg Psychiatry; 1998 Jan; 64(1):78-83. PubMed ID: 9436732
[TBL] [Abstract][Full Text] [Related]
11. A national epidemiological study of Myasthenia Gravis in Australia.
Gattellari M; Goumas C; Worthington JM
Eur J Neurol; 2012 Nov; 19(11):1413-20. PubMed ID: 22469211
[TBL] [Abstract][Full Text] [Related]
12. Myasthenia Gravis in Poland: National Healthcare Database Epidemiological Study.
Sobieszczuk E; Napiórkowski Ł; Szczudlik P; Kostera-Pruszczyk A
Neuroepidemiology; 2021 Feb; ():1-8. PubMed ID: 33611318
[TBL] [Abstract][Full Text] [Related]
13. Perioperative risk factors for occurrence of myasthenia gravis after thymectomy in patients with thymoma.
Zhang X; Li B; Zou J; Su C; Zhu H; Chen T; Luo H; Chen Z; Zhang S
Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):519-526. PubMed ID: 32862219
[TBL] [Abstract][Full Text] [Related]
14. Incidence and characteristics of Myasthenia gravis in Dar Es Salaam, Tanzania.
Matuja WB; Aris EA; Gabone J; Mgaya EM
East Afr Med J; 2001 Sep; 78(9):473-6. PubMed ID: 11921580
[TBL] [Abstract][Full Text] [Related]
15. Surgical and neurologic outcomes after robotic thymectomy in 100 consecutive patients with myasthenia gravis.
Marulli G; Schiavon M; Perissinotto E; Bugana A; Di Chiara F; Rebusso A; Rea F
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):730-5; discussion 735-6. PubMed ID: 23312969
[TBL] [Abstract][Full Text] [Related]
16. Mortality of myasthenia gravis: a national population-based study in China.
Zhang C; Wang F; Long Z; Yang J; Ren Y; Ma Q; Li J; Wen X; Wang L; Da Y; Zhou M; Yin P; Hao J
Ann Clin Transl Neurol; 2023 Jul; 10(7):1095-1105. PubMed ID: 37212271
[TBL] [Abstract][Full Text] [Related]
17. Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry.
Ramos-Fransi A; Rojas-García R; Segovia S; Márquez-Infante C; Pardo J; Coll-Cantí J; Jericó I; Illa I;
Eur J Neurol; 2015 Jul; 22(7):1056-61. PubMed ID: 25847221
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of myasthenia gravis in southern China: a retrospective review of 2,154 cases over 22 years.
Huang X; Liu WB; Men LN; Feng HY; Li Y; Luo CM; Qiu L
Neurol Sci; 2013 Jun; 34(6):911-7. PubMed ID: 22806326
[TBL] [Abstract][Full Text] [Related]
19. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
